The Research and Development team at Xap Therapeutics focuses on pioneering advancements in cell therapeutics using synthetic biology. This team is responsible for designing, developing, and optimizing genetically engineered "chassis" cells that serve as the foundation for innovative cell therapy treatments. Their work includes upstream research, cell line engineering, and continuous improvement of platform technologies to revolutionize therapeutic outcomes.
View all